Susquehanna International Group, LLP Stoke Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	BUY	$4.12 - $14.17 $41,612 - $143,117	10,100 New	10,100 $136,000
Q2 2021 Aug 11, 2021	BUY	$30.53 - $41.09 $607,547 - $817,691	19,900 Added 114.37%	37,300 $1.26 Million
Q1 2021 May 17, 2021	BUY	$36.08 - $69.81 $122,672 - $237,354	3,400 Added 24.29%	17,400 $676,000
Q4 2020 Feb 16, 2021	BUY	$33.62 - $61.93 $57,153 - $105,281	1,700 Added 13.82%	14,000 $867,000
Q3 2020 Nov 16, 2020	SELL	$22.23 - $37.48 $44,460 - $74,960	-2,000 Reduced 13.99%	12,300 $412,000
Q2 2020 Aug 14, 2020	BUY	$20.26 - $29.73 $289,718 - $425,139	14,300 New	14,300 $341,000

123

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $474M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.